Aerpio Pharmaceuticals, Inc.
ARPO · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $59 | $75 | $53 | $16 |
| - Cash | $29 | $15 | $10 | $10 |
| + Debt | $1 | $0 | $0 | $0 |
| Enterprise Value | $32 | $61 | $43 | $6 |
| Revenue | $26 | $6 | $4 | $1 |
| % Growth | 371.7% | 23.1% | 443.6% | – |
| Gross Profit | $0 | -$30 | -$16 | -$14 |
| % Margin | 0% | -535.7% | -347.4% | -1,655% |
| EBITDA | -$67 | -$36 | -$23 | -$20 |
| % Margin | -259.6% | -654.6% | -506.3% | -2,487.6% |
| Net Income | -$64 | -$37 | -$23 | -$22 |
| % Margin | -245.1% | -670.2% | -517.5% | -2,695.1% |
| EPS Diluted | -2.36 | -1.08 | -0.96 | -1.35 |
| % Growth | -118.5% | -12.5% | 28.9% | – |
| Operating Cash Flow | -$60 | -$32 | -$24 | -$18 |
| Capital Expenditures | -$2 | -$2 | -$1 | -$1 |
| Free Cash Flow | -$61 | -$35 | -$25 | -$19 |